Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Developmental moisturizing cream 2-GlaxoSmithKline is an experimental topical cosmetic formulation developed by GSK. It was designed to improve skin barrier function and hydration in individuals with dry, sensitive skin. In clinical testing (NCT02814123), the formulation was applied topically twice daily to the face and legs over a four-week period to evaluate its impact on skin barrier integrity and moisture levels compared to a standard cleanser and another developmental formulation. The study utilized healthy participants with dry, sensitive skin to assess the efficacy of the cream in restoring barrier function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on developmental moisturizing cream 2-GlaxoSmithKline.